The use of umbilical cord blood as a cellular source for correction of genetic diseases affecting the hematopoietic system

STEM CELLS

Volumn 13, Issue 6, 1995, Pages 613-621

  Clapp, D Wade ^a   Williams, David A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cord blood; Gene therapy; Gene transfer; Hematopoiesis; Ontogeny; Retroviral vectors

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; CELL ANTIGEN; CYTOKINE; FLUOROURACIL; INTERLEUKIN 6; STEM CELL FACTOR;

ANIMAL CELL; BONE MARROW CELL; CELL CULTURE; CELL TRANSPLANTATION; COLONY FORMING CELL; EXTRACELLULAR MATRIX; GENE TRANSFER; GENETIC DISORDER; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PLACENTA CIRCULATION; PRENATAL DIAGNOSIS; RETROVIRUS; REVIEW; UMBILICAL CORD BLOOD;

ANIMAL; FETAL BLOOD; GENE TRANSFER TECHNIQUES; HEMATOLOGIC DISEASES; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMAN; MICE; PRENATAL DIAGNOSIS; RETROVIRIDAE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSDUCTION, GENETIC;

EID: 0028787058     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.5530130606     Document Type: Article

References (87)

1. Haematopoietic cells
2. Ontogeny of the hematopoietic system: yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo
3. Human embryonic hemopoiesis—kinetics of progenitors and precursors underlying the yolk sac→liver transition
4. Totipotent hematopoietic stem cells: normal self‐renewal and differentiation after transplantation between mouse fetuses
5. Cellular and developmental properties of fetal hematopoietic stem cells
6. Fetal liver hematopoietic stem cells as a target for in utero retroviral gene transfer
7. Myeloproliferative sarcoma virus directed expression of β‐galactosidase following retroviral transduction of murine hematopoietic cells
8. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells
9. +++ human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential
10. Granulocyte‐macrophage progenitor cells in term and preterm infants
11. Gestational age dependent changes in circulating hematopoietic stem cells in newborn infants
12. Hematopoietic reconstitution in a patient with Fanconi anemia by means of umbilical cord blood from an HLA‐identical sibling
13. Human multipotential progenitor cells (CFU‐GEMM) have extensive replating capacity for secondary CFU‐GEMM: an effect enhanced by cord blood plasma
14. Ontogeny‐related changes in proliferative potential of human hematopoietic cells
15. Studies of circulating hematopoietic progenitor cells in human fetal blood
16. Growth of human umbilical cord blood in long term haematopoietic cultures
17. Characterization of hematopoietic cell populations in term and preterm infants
18. Development of pluripotent hematopoietic progenitor cells in human fetal blood
19. Haematopoietic stem/progenitor cell transplant in Fanconi anemia using HLA‐matched sibling umbilical cord blood cells
20. Umbilical cord blood transplantation in a patient with Philadelphia chromosome‐positive chronic myeloid leukemia
21. Correction of x‐linked lymphoproliferative disease by transplantation of cord blood stem cells
22. Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment
23. Successful hematopoietic reconstitution of erythrocyte‐depleted allogeneic human umbilical cord blood cells in a child with leukemia
24. Umbilical cord blood infusion in a patient for correction of Wiskott Aldrich Syndrome
25. Brief report: transplantation of cord‐blood stem cells into a patient with severe thalassemia
26. HLA‐mismatched cord blood transplantation in a patient with advanced leukemia
27. The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation
28. Transplantation of umbilical cord blood in 50 patients: analysis of the registry data
29. Human cord blood as targets for gene transfer. Potential use in genetic therapies of severe combined immunodeficiency disease
30. +++ hematopoietic stem/progenitor cells from human umbilical cord blood
31. + cells
32. Preimplantation genetic diagnosis
33. Midtrimester amniocentesis for prenatal diagnosis: safety and accuracy
34. A randomized comparison of transcervical and transabdominal chorionic villus sampling. The U.S. National Institute of Child Health and Human Development Chorionic‐Villus Sampling and Amniocentesis Study Group
35. MRC Working Party on the Evaluation of Chorion Villus Sampling. Medical research council European trial of chorion villus sampling
36. Editorial. Chorion villus sampling: valuable addition or dangerous alternative
37. Transvaginal chorionic villus sampling using transabdominal ultrasound guidance: A new technique for first‐trimester prenatal diagnosis
38. Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation
39. Direct comparison by limiting dilution analysis of longterm culture‐initiating cells in human bone marrow, umbilical cord blood, and blood stem cells
40. + cord blood cells in the presence of recombinant human stem cell factor
41. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers
42. − human umbilical cord blood cells reveals their potentiality to engraft adults
43. Stored placental blood for unrelated bone marrow reconstitution
44. Umbilical cord blood stem cell transplantation
45. Retrovirus transfer of a bacterial gene into mouse haematopoietic progenitor cells
46. Introduction of new genetic material into pluripotential stem cells of the mouse
47. Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors
48. Introduction of a selectable gene in primitive stem cells capable of long‐term reconstitution of the hematopoietic system of w/wv mice
49. Developmental potential and dynamic behavior of hematopoietic stem cells
50. Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus‐mediated gene transfer into hematopoietic stem cells
51. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
52. Safe and efficient generation of recombinant retroviruses with amphotropic and ectropic host ranges
53. Expression of human adenosine deaminase in murine hematopoietic cells
54. Long‐term expression of human adenosine deaminase in mice transplanted with retrovirus‐infected hematopoietic stem cells
55. A safe packaging line for gene transfer. Separating viral genes on two different plasmids
56. Construction and use of a safe and efficient amphotropic packaging cell line
57. Expression of the human β‐globin gene following retroviral‐mediated transfer into multipotential hematopoietic progenitors of mice
58. A majority of mice show long‐term expression of a human β‐globin gene after retrovirus transfer into hematopoietic stem cells
59. Survival and retrovirus infection of murine hematopoietic stem cells in vitro: effects of 5‐FU and method of infection
60. Stem cell factor (SCF) increases CFU‐S number in vivo and in vitro in synergy with interleukin‐6
61. Retroviral gene transfer of human adenosine in murine hematopoietic cells: effect of selectable marker sequences on long term expression
62. Long and short lived murine hematopoietic stem cell clones individually identified with retroviral integration markers
63. Canine model for gene therapy: inefficient gene expression in dogs reconstituted with autologous marrow infected with retroviral vectors
64. Retroviral transfer of genes into canine hematopoietic progenitor cells in culture: a model for human gene therapy
65. Gene transfer into hematopoietic progenitor cells from normal and cyclic hematopoietic dogs using retroviral vectors
66. Improved retroviral transfer of genes into canine hematopoietic progenitor cells kept in long‐term marrow culture
67. Long‐term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus‐infected bone‐marrow cells
68. + bone marrow cells
69. Autologous transplantation of canine long‐term marrow culture cells genetically marked by retroviral vectors
70. The contribution of autologous marrow infusion to the restoration of long‐term hemopoiesis in cancer patients: a study using gene marking
71. Human cord blood cells as targets for gene transfer: potential use in genetic therapies of severe combined immunodeficiency disease
72. In utero gene transfer and expression. A sheep transplantation model
73. Umbilical cord blood cell transduction by retroviral vectors. Preclinical studies to optimize gene transfer
74. Physiological mechanisms of stem cell regulation in bone marrow transplantation and haemopoiesis (review)
75. Soluble factor(s) produced by human bone marrow stroma increase cytokine‐induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation
76. Stimulation of multipotential erythroid and other murine haematopoietic progenitor cells by adherent cell lines in the absence of detectable multi‐CSF (IL‐3)
77. Bone marrow stromal cell lines with lymphopoietic activity express high levels of pre‐B neoplasia‐associated molecule
78. Generation of murine stromal cell lines supporting hematopoietic stem cell proliferation by use of recombinant retrovirus vectors encoding simian virus 40 large T antigen
79. Systematic analysis of the ability of stromal cell lines derived from different murine adult tissues to support maintenance of hematopoietic stem cells
80. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c‐kit tyrosine kinase receptor
81. Fibronectin and VLA‐4 in haematopoietic stem cell‐microenvironment interactions
82. Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin
83. Human cord blood cells as targets for gene transfer. Potential use in genetic therapies of severe combined immunodeficiency disease
84. Umbilical cord blood stem cells as targets for genetic modification: new therapeutic approaches to somatic gene therapy